Anti-tumour activity of tivozanib, a pan-inhibitor of VEGF receptors, in therapy-resistant ovarian carcinoma cells

por Momeny, Majid, Sabourinejad, Zahra, Zarrinrad, Ghazaleh, Moghaddaskho, Farima, Eyvani, Haniyeh, Yousefi, Hassan, Mirshahvaladi, Shahab, Poursani, Ensieh M., Barghi, Farinaz, Poursheikhani, Arash, Dardaei, Leila, Bashash, Davood, Ghazi-Khansari, Mahmoud, Tavangar, Seyyed M., Dehpour, Ahmad R., Yaghmaie, Marjan, Alimoghaddam, Kamran, Ghavamzadeh, Ardeshir, Ghaffari, Seyed H.
Publicado 2017

An organoid-based screen for epigenetic inhibitors that stimulate antigen presentation and potentiate T-cell-mediated cytotoxicity

por Zhou, Zhuolong, Van der Jeught, Kevin, Fang, Yuanzhang, Yu, Tao, Li, Yujing, Ao, Zheng, Liu, Sheng, Zhang, Lu, Yang, Yang, Eyvani, Haniyeh, Cox, Mary L., Wang, Xiyu, He, Xiaoming, Ji, Guang, Schneider, Bryan P., Guo, Feng, Wan, Jun, Zhang, Xinna, Lu, Xiongbin
Publicado 2021

Blockade of vascular endothelial growth factor receptors by tivozanib has potential anti-tumour effects on human glioblastoma cells

por Momeny, Majid, Moghaddaskho, Farima, Gortany, Narges K., Yousefi, Hassan, Sabourinejad, Zahra, Zarrinrad, Ghazaleh, Mirshahvaladi, Shahab, Eyvani, Haniyeh, Barghi, Farinaz, Ahmadinia, Leila, Ghazi-Khansari, Mahmoud, Dehpour, Ahmad R., Amanpour, Saeid, Tavangar, Seyyed M., Dardaei, Leila, Emami, Amir H., Alimoghaddam, Kamran, Ghavamzadeh, Ardeshir, Ghaffari, Seyed H.
Publicado 2017

Dacomitinib, a pan-inhibitor of ErbB receptors, suppresses growth and invasive capacity of chemoresistant ovarian carcinoma cells

por Momeny, Majid, Zarrinrad, Ghazaleh, Moghaddaskho, Farima, Poursheikhani, Arash, Sankanian, Ghazaleh, Zaghal, Azam, Mirshahvaladi, Shahab, Esmaeili, Fatemeh, Eyvani, Haniyeh, Barghi, Farinaz, Sabourinejad, Zahra, Alishahi, Zivar, Yousefi, Hassan, Ghasemi, Reza, Dardaei, Leila, Bashash, Davood, Chahardouli, Bahram, Dehpour, Ahmad R., Tavakkoly-Bazzaz, Javad, Alimoghaddam, Kamran, Ghavamzadeh, Ardeshir, Ghaffari, Seyed H.
Publicado 2017

Targeting 17q23 amplicon to overcome the resistance to anti-HER2 therapy in HER2+ breast cancer

por Liu, Yunhua, Xu, Jiangsheng, Choi, Hyun Ho, Han, Cecil, Fang, Yuanzhang, Li, Yujing, Van der Jeught, Kevin, Xu, Hanchen, Zhang, Lu, Frieden, Michael, Wang, Lifei, Eyvani, Haniyeh, Sun, Yifan, Zhao, Gang, Zhang, Yuntian, Liu, Sheng, Wan, Jun, Huang, Cheng, Ji, Guang, Lu, Xiongbin, He, Xiaoming, Zhang, Xinna
Publicado 2018